Cronyxin 50 mg/g Oral Paste for Horses

国: イギリス

言語: 英語

ソース: VMD (Veterinary Medicines Directorate)

有効成分:

Flunixin

から入手可能:

Bimeda Animal Health Limited

ATCコード:

QM01AG90

INN（国際名）:

Flunixin

医薬品形態:

Oral paste

処方タイプ:

POM-V - Prescription Only Medicine – Veterinarian

治療群:

Horses

治療領域:

Anti Inflammatory NSAID

認証ステータス:

Authorized

承認日:

2018-11-01

製品の特徴

Revised: March 2023
AN: 00443/2022
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Cronyxin 50 mg/g Oral paste for horses
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 g of paste contains:
ACTIVE SUBSTANCE:
Flunixin
50 mg
(as Flunixin meglumine
83 mg)
EXCIPIENTS:
QUALITATIVE COMPOSITION OF EXCIPIENTS
AND OTHER CONSTITUENTS
Silica, colloidal anhydrous
Propylene glycol
Titanium dioxide (E171)
Xanthan gum
Aluminium magnesium silicate
Sorbitol, liquid (crystallising)
Apple flavour FL02791
Purified water
White to off-white paste
3.
CLINICAL INFORMATION
3.1
TARGET SPECIES
Horses
3.2
INDICATIONS FOR USE FOR EACH TARGET SPECIES
Treatment of acute inflammatory musculoskeletal disorders in horses.
3.3
CONTRAINDICATIONS
Do not exceed the stated dose or duration of treatment.
Do not administer other NSAIDs or glucocorticosteroids concurrently or
within
24 hours of each other.
Do not use in animals suffering from cardiac, hepatic or renal
disease.
Do not use in animals suspected of having gastrointestinal ulceration
or bleeding.
Do not use in case of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in dehydrated or hypovolaemic animals, except in the case
of
endotoxaemia or septic shock, as there is a potential risk of
increased renal toxicity.
Do not use in animals suffering from chronic musculoskeletal
disorders.
See also section 3.7.
Revised: March 2023
AN: 00443/2022
Page 2 of 5
3.4
SPECIAL WARNINGS
Use of the veterinary medicinal product may lead to temporary relief
due to its
ameliorating effects on inflammatory signs. This may appear as
effective treatment of
the underlying disease.
The cause of the underlying inflammatory condition should be
determined and
treated with appropriate concomitant therapy.
3.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for safe use in the target species
Animals should be rested and a sufficient supply of drinking water has
to be ensured
during the course of treatment with the veterinary medicinal product.
Use i